Abstract:Extracellular vesicles (EVs) have emerged as important carriers for intercellular communication and biological sources for diagnosis and therapeutics. Low efficiency in EV isolation from biofluids, however, severely restricts their downstream characterization and analysis. Here, we introduced a novel strategy for EV isolation from urine for prostate cancer diagnosis using bifunctionalized magnetic beads through high affinity Ti(IV) ions and the insertion of a phospholipid derivative, 1,2-distearoyl-<i>sn</i>-glycero-3-phosphoethanolamine, into the EV membrane synergistically. We demonstrated its efficient isolation of EVs from urine samples with low contamination, high recovery (>80%), and short separation time (within 1 h), resulting in the identification of 36,262 unique EV peptides corresponding to 3302 unique proteins and 3233 unique phosphopeptides representing 1098 unique phosphoproteins using only 100 μL and 5 mL urine samples, respectively. Coupled with trapped ion mobility spectrometry and parallel accumulation–serial fragmentation for phosphosite-specific resolution, quantitative phosphoproteomics of urine samples from prostate cancer patients and healthy individuals revealed 121 upregulated phosphoproteins in cancer patients in contrast to the healthy group. These particular advantages indicate that the novel bifunctional material enables sensitive EV phosphoproteomic analysis for noninvasive biomarker screening and early cancer diagnosis.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsami.0c19400?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsami.0c19400</a>.FTIR, zeta potential, and fluorescence characterization of the different MBs-based materials (Figure S1); size distribution characterization of EVs isolated using UC, TiMBs, and DspeMBs (Figure S2); whole proteome overlap among different methods and top proteins of exosome and the phosphopeptides analysis of different isolation methods (Figure S3); Pearson correlation of EV proteomes of the clinical urine samples (Figure S4); the interaction pathway of the upregulated phosphoproteins (Figure S5); fold increase in these 13 exosomal proteins and 3 free urine proteins from LC–MS data of different methods compared to the UC sample (Table S2); and the list of the cancer-associated upregulated phosphoproteins (Table S5) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_001.pdf">PDF</a>)LC–MS whole proteome analysis data of EVs isolated by different methods (Table S1) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_002.xlsx">XLSX</a>)LC–MS phosphoproteome analysis data of EVs isolated by different methods (Table S3) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_003.xlsx">XLSX</a>)LC–MS prostate cancer-specific EV phosphoproteins analysis data (Table S4) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_004.xlsx">XLSX</a>)Mobility resolution of phosphorylation site isomers in urine EVs from prostate cancer patients (Table S6) (<a class="ext-link" href="/doi/suppl/10.1021/acsami.0c19400/suppl_file/am0c19400_si_005.xlsx">XLSX</a>)This article has not yet been cited by other publications.

Synergistically Bifunctional Paramagnetic Separation Enables Efficient Isolation of Urine Extracellular Vesicles and Downstream Phosphoproteomic Analysis

Proteomics, Phosphoproteomics and Mirna Analysis of Circulating Extracellular Vesicles Through Automated and High-Throughput Isolation.

Glass Fiber-Supported Hybrid Monolithic Spin Tip for Enrichment of Phosphopeptides from Urinary Extracellular Vesicles

High Throughput Isolation and Data Independent Acquisition Mass Spectrometry (DIA-MS) of Urinary Extracellular Vesicles to Improve Prostate Cancer Diagnosis

Profiling Phosphoproteome Landscape in Circulating Extracellular Vesicles from Microliters of Biofluids Through Functionally Tunable Paramagnetic Separation.

Assessment of urine sample collection and processing variables for extracellular vesicle-based proteomics

Immunomagnetic sequential ultrafiltration (iSUF) platform for enrichment and purification of extracellular vesicles from biofluids

An Integrated Double-Filtration Microfluidic Device for Detection of Extracellular Vesicles from Urine for Bladder Cancer Diagnosis.

A Facile “One-Material” Strategy for Tandem Enrichment of Small Extracellular Vesicles Phosphoproteome

High-Efficiency Capture and Proteomic Analysis of Plasma-Derived Extracellular Vesicles through Affinity Purification

A Magnetic Bead-Mediated Selective Adsorption Strategy for Extracellular Vesicle Separation and Purification.

Optimized workflow of EV enrichment from human plasma samples for downstream mass spectrometry analysis

Metabolic landscaping of extracellular vesicles from body fluids by phosphatidylserine imprinted polymer enrichment and mass spectrometry analysis

A Magnetically Driven Tandem Chip Enables Rapid Isolation and Multiplexed Profiling of Extracellular Vesicles

Reversible Zwitterionic Coordination Enables Rapid, High-Yield, and High-Purity Isolation of Extracellular Vesicles from Biofluids

High-Throughput and Automated Acoustic Trapping of Extracellular Vesicles to Identify microRNAs With Diagnostic Potential for Prostate Cancer

Diagnosis of Prostate Cancer Metastasis via Extracellular Vesicles Isolated Using Two‐Phase Interface as Membrane‐Less Filter

Enhanced proteomic profiling of human plasma‐derived extracellular vesicles through charge‐based fractionation to advance biomarker discovery potential

Optimizing Size Exclusion Chromatography for Extracellular Vesicle Enrichment and Proteomic Analysis from Clinically Relevant Samples

An integrated double-filtration microfluidic device for isolation, enrichment and quantification of urinary extracellular vesicles for detection of bladder cancer

One-pot preparation of bi-functional POSS-based hybrid monolith via photo-initiated polymerization for isolation of extracellular vesicles